PixarBio Corporation operates as a specialized pharmaceutical and biotechnology firm, primarily dedicated to the pre-clinical and clinical advancement of neurological drug delivery systems. Initially, their focus is on alleviating post-surgical pain. Beyond this, the company's extensive research and development initiatives encompass crafting innovative delivery platforms for a variety of pharmaceuticals, medical devices, or biological therapies.